Home > Quotes > GENE > Company Financials
GENE

GENE Company Financials

$3.1
*  
0.01
  negative  
0.32%
Get GENE Alerts
*Delayed - data as of May 24, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 6/30/2012 6/30/2011 6/30/2010 6/30/2009
Total Revenue
$3,691 $4,595 $4,916 $3,718
Cost of Revenue
$1,949 $2,035 $2,723 $2,232
Gross Profit
$1,743 $2,560 $2,193 $1,487
Operating Expenses
Research and Development
$4,029 $4,381 $6,259 $4,945
Sales, General and Admin.
$3,010 ($2,701) $5,735 $4,659
Non-Recurring Items
$0 $0 $0 $0
Other Operating Items
$0 $0 $0 $0
Operating Income
($5,297) $880 ($9,801) ($8,117)
Add'l income/expense items
$0 $0 $0 $1,138
Earnings Before Interest and Tax
($5,297) $901 ($9,355) ($6,353)
Interest Expense
$0 $0 $0 $0
Earnings Before Tax
($5,297) $901 ($9,355) ($6,353)
Income Tax
$0 $0 $0 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($5,297) $901 ($9,355) ($6,353)
Net Income
($5,297) $901 ($9,355) ($6,353)
Net Income Applicable to Common Shareholders
($5,297) $901 ($9,355) ($6,353)

See also: Company Financials data entry page